Letter

Angiotensin receptor blockers and myocardial infarction

BMJ 2005; 330 doi: 10.1136/bmj.330.7502.1270 (Published 26 May 2005)
Cite this as: BMJ 2005;330:1270.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Direct comparative studies are needed

  1. Lionel H Opie, director (opie@capeheart.uct.ac.za)1
  1. 1 Hatter Institute, University of Cape Town, Medical School, Observatory, Cape Town, South Africa

    Editor—The editorial by Verma and Strauss does not accord with the BMJ's usual impartial evidence based approach.1 Evidence that angiotensin receptor blockers increase myocardial infarction is scant, and I remain puzzled about what exactly patients should be told—that the BMJ published an incorrect analysis?

    Regarding angiotensin receptor blockers and myocardial infarction in hypertension, the …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular